Evaluation of Adjuvant Radiation Therapy for Resected Gallbladder Carcinoma: A Multi-institutional Experience

Jingya Wang, Amol K. Narang, Elizabeth A. Sugar, Brandon Luber, Lauren M. Rosati, Charles C. Hsu, Clifton D. Fuller, Timothy M. Pawlik, Robert C. Miller, Brian G. Czito, Richard Tuli, Christopher H. Crane, Edgar Ben-Josef, Charles R. Thomas, Joseph M. Herman

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Purpose: The role of adjuvant radiation for gallbladder carcinoma (GBC) is uncertain. We combine the experience of six National Cancer Institute-designated cancer centers to explore the impact of adjuvant radiation following oncologic resection of GBC. Methods: Patients who underwent extended surgery for GBC at Johns Hopkins, Mayo Clinic, Duke University, Oregon Health & Science University, University of Michigan, and University of Texas MD Anderson between 1985 and 2008 were reviewed. Patients with metastatic disease at surgery, gross residual disease, or missing pathologic information were excluded. Results: Of the 112 patients identified, 61 % received adjuvant radiation, 93 % of whom received concurrent chemotherapy. Median follow-up of surviving patients was 47.3 (range 2.2–167.7) months. Patients who received adjuvant radiation had a higher rate of advanced T-stage (57 vs. 16 %, p 

Original languageEnglish (US)
Pages (from-to)1100-1106
Number of pages7
JournalAnnals of Surgical Oncology
Volume22
DOIs
StatePublished - Dec 1 2015

Fingerprint

Gallbladder
Radiotherapy
Carcinoma
Radiation
National Cancer Institute (U.S.)
Drug Therapy
Health
Neoplasms

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Wang, J., Narang, A. K., Sugar, E. A., Luber, B., Rosati, L. M., Hsu, C. C., ... Herman, J. M. (2015). Evaluation of Adjuvant Radiation Therapy for Resected Gallbladder Carcinoma: A Multi-institutional Experience. Annals of Surgical Oncology, 22, 1100-1106. https://doi.org/10.1245/s10434-015-4685-y

Evaluation of Adjuvant Radiation Therapy for Resected Gallbladder Carcinoma : A Multi-institutional Experience. / Wang, Jingya; Narang, Amol K.; Sugar, Elizabeth A.; Luber, Brandon; Rosati, Lauren M.; Hsu, Charles C.; Fuller, Clifton D.; Pawlik, Timothy M.; Miller, Robert C.; Czito, Brian G.; Tuli, Richard; Crane, Christopher H.; Ben-Josef, Edgar; Thomas, Charles R.; Herman, Joseph M.

In: Annals of Surgical Oncology, Vol. 22, 01.12.2015, p. 1100-1106.

Research output: Contribution to journalArticle

Wang, J, Narang, AK, Sugar, EA, Luber, B, Rosati, LM, Hsu, CC, Fuller, CD, Pawlik, TM, Miller, RC, Czito, BG, Tuli, R, Crane, CH, Ben-Josef, E, Thomas, CR & Herman, JM 2015, 'Evaluation of Adjuvant Radiation Therapy for Resected Gallbladder Carcinoma: A Multi-institutional Experience', Annals of Surgical Oncology, vol. 22, pp. 1100-1106. https://doi.org/10.1245/s10434-015-4685-y
Wang, Jingya ; Narang, Amol K. ; Sugar, Elizabeth A. ; Luber, Brandon ; Rosati, Lauren M. ; Hsu, Charles C. ; Fuller, Clifton D. ; Pawlik, Timothy M. ; Miller, Robert C. ; Czito, Brian G. ; Tuli, Richard ; Crane, Christopher H. ; Ben-Josef, Edgar ; Thomas, Charles R. ; Herman, Joseph M. / Evaluation of Adjuvant Radiation Therapy for Resected Gallbladder Carcinoma : A Multi-institutional Experience. In: Annals of Surgical Oncology. 2015 ; Vol. 22. pp. 1100-1106.
@article{e5b211f84b6f43b581fd08f8c80e32c5,
title = "Evaluation of Adjuvant Radiation Therapy for Resected Gallbladder Carcinoma: A Multi-institutional Experience",
abstract = "Purpose: The role of adjuvant radiation for gallbladder carcinoma (GBC) is uncertain. We combine the experience of six National Cancer Institute-designated cancer centers to explore the impact of adjuvant radiation following oncologic resection of GBC. Methods: Patients who underwent extended surgery for GBC at Johns Hopkins, Mayo Clinic, Duke University, Oregon Health & Science University, University of Michigan, and University of Texas MD Anderson between 1985 and 2008 were reviewed. Patients with metastatic disease at surgery, gross residual disease, or missing pathologic information were excluded. Results: Of the 112 patients identified, 61 {\%} received adjuvant radiation, 93 {\%} of whom received concurrent chemotherapy. Median follow-up of surviving patients was 47.3 (range 2.2–167.7) months. Patients who received adjuvant radiation had a higher rate of advanced T-stage (57 vs. 16 {\%}, p ",
author = "Jingya Wang and Narang, {Amol K.} and Sugar, {Elizabeth A.} and Brandon Luber and Rosati, {Lauren M.} and Hsu, {Charles C.} and Fuller, {Clifton D.} and Pawlik, {Timothy M.} and Miller, {Robert C.} and Czito, {Brian G.} and Richard Tuli and Crane, {Christopher H.} and Edgar Ben-Josef and Thomas, {Charles R.} and Herman, {Joseph M.}",
year = "2015",
month = "12",
day = "1",
doi = "10.1245/s10434-015-4685-y",
language = "English (US)",
volume = "22",
pages = "1100--1106",
journal = "Annals of Surgical Oncology",
issn = "1068-9265",
publisher = "Springer New York",

}

TY - JOUR

T1 - Evaluation of Adjuvant Radiation Therapy for Resected Gallbladder Carcinoma

T2 - A Multi-institutional Experience

AU - Wang, Jingya

AU - Narang, Amol K.

AU - Sugar, Elizabeth A.

AU - Luber, Brandon

AU - Rosati, Lauren M.

AU - Hsu, Charles C.

AU - Fuller, Clifton D.

AU - Pawlik, Timothy M.

AU - Miller, Robert C.

AU - Czito, Brian G.

AU - Tuli, Richard

AU - Crane, Christopher H.

AU - Ben-Josef, Edgar

AU - Thomas, Charles R.

AU - Herman, Joseph M.

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Purpose: The role of adjuvant radiation for gallbladder carcinoma (GBC) is uncertain. We combine the experience of six National Cancer Institute-designated cancer centers to explore the impact of adjuvant radiation following oncologic resection of GBC. Methods: Patients who underwent extended surgery for GBC at Johns Hopkins, Mayo Clinic, Duke University, Oregon Health & Science University, University of Michigan, and University of Texas MD Anderson between 1985 and 2008 were reviewed. Patients with metastatic disease at surgery, gross residual disease, or missing pathologic information were excluded. Results: Of the 112 patients identified, 61 % received adjuvant radiation, 93 % of whom received concurrent chemotherapy. Median follow-up of surviving patients was 47.3 (range 2.2–167.7) months. Patients who received adjuvant radiation had a higher rate of advanced T-stage (57 vs. 16 %, p 

AB - Purpose: The role of adjuvant radiation for gallbladder carcinoma (GBC) is uncertain. We combine the experience of six National Cancer Institute-designated cancer centers to explore the impact of adjuvant radiation following oncologic resection of GBC. Methods: Patients who underwent extended surgery for GBC at Johns Hopkins, Mayo Clinic, Duke University, Oregon Health & Science University, University of Michigan, and University of Texas MD Anderson between 1985 and 2008 were reviewed. Patients with metastatic disease at surgery, gross residual disease, or missing pathologic information were excluded. Results: Of the 112 patients identified, 61 % received adjuvant radiation, 93 % of whom received concurrent chemotherapy. Median follow-up of surviving patients was 47.3 (range 2.2–167.7) months. Patients who received adjuvant radiation had a higher rate of advanced T-stage (57 vs. 16 %, p 

UR - http://www.scopus.com/inward/record.url?scp=84952872084&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84952872084&partnerID=8YFLogxK

U2 - 10.1245/s10434-015-4685-y

DO - 10.1245/s10434-015-4685-y

M3 - Article

C2 - 26224402

AN - SCOPUS:84952872084

VL - 22

SP - 1100

EP - 1106

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

SN - 1068-9265

ER -